Yang, Libing
Haidar, Ghady
Zia, Haris
Nettles, Rachel
Qin, Shulin
Wang, Xiaohong
Shah, Faraaz
Rapport, Sarah F.
Charalampous, Themoula
Methé, Barbara
Fitch, Adam
Morris, Alison
McVerry, Bryan J.
O’Grady, Justin
Kitsios, Georgios D. http://orcid.org/0000-0002-1018-948X
Funding for this research was provided by:
Foundation for the National Institutes of Health (K23 HL139987, U01 HL098962, P01 HL114453, R01 HL097376, K24 HL123342, K23 GM122069)
National Institute for Health Research (RP-PG-0514-20018)
UK Antimicrobial Resistance Cross Council Initiative (MR/N013956/1)
Rosetrees Trust (A749)
Biotechnology and Biological Sciences Research Council (BB/R012504/1, BBS/E/F/000PR10348, BBS/E/F/000PR10349)
Article History
Received: 27 August 2019
Accepted: 15 October 2019
First Online: 27 November 2019
Ethics approval and consent to participate
: This study was approved by the University of Pittsburgh Institutional Review Board (Protocol PRO10110387). Written informed consent was provided by all participants or their surrogates in accordance with the Declaration of Helsinki.
: Written informed consent was provided by all participants or their surrogates in accordance with the Declaration of Helsinki.
: Dr. Bryan J. McVerry is a consultant for Vapotherm, Inc. Dr. Georgios Kitsios receives research funding from Karius, Inc. Dr. Justin O’Grady receives (or received) research funding and consumable support from Oxford Nanopore Technologies (ONT) and financial support for attending conferences and for speaking at ONT headquarters. Dr. Themoula Charalampous received financial support from ONT for attending an international conference.Dr. Themoula Charalampous received financial support from ONT for attending an international conference. The other authors have no conflicts of interest to declare.